Mottin Benoît, Baruteau Alban, Boudjemline Younes, Piéchaud François J, Godart François, Lusson Jean-René, Hascoet Sebastien, Le Gloan Laurianne, Fresse Karine Warin, Guyomarch Beatrice, Bouzguenda Ivan, Malekzadeh-Milani Sophie, Petit Jerome, Guérin Patrice
Institut Du Thorax, Centre Hospitalier Universitaire De Nantes, France.
Centre Médico-Chirurgical De Marie Lannelongue, Le Plessis Robinson, France.
Catheter Cardiovasc Interv. 2016 Feb 15;87(3):411-8. doi: 10.1002/ccd.26320. Epub 2015 Nov 3.
The short-term efficacy and safety of transcatheter closure (TCC) for the management of coronary artery fistulas (CAFs) was investigated in pediatric patients.
CAFS are rare with potentially severe complications and their management is still a matter of debate. Percutaneous closure appears to be the treatment of choice in anatomically suitable vessels but limited data are available in the pediatric population.
This retrospective, observational, multicenter, national study included patients under 16 years of age who underwent TCC of a congenital CAF. Patients with additional congenital heart defect were excluded.
61 patients (36 girls, 25 boys) with a median age of 0.6 year [0-15.4] at diagnosis and 3.9 years [0-16] at procedure were included. The CAF was large in 48 patients (79%); it was distal in 23 (38%) and proximal in 22 (36%). Most patients (77%) were asymptomatic at diagnosis. Clinical signs of congestive heart failure were present in seven patients (11%). Perioperative complications included three cases of ST elevation myocardial infarction (exclusively during attempted closure of a distal CAF), three devices migrations, and one case of leg ischemia. One patient died after surgical closure of a large distal CAF that could not be closed by TCC. Follow-up data were collected for 43 patients (70%) for a median of 91 days [0-4,824]. The Kaplan-Meyer estimate for complete occlusion at 2 years was 73 ± 7.6%.
TCC in the pediatric population appears to be effective and associated with few complications.
研究经导管封堵术(TCC)治疗小儿冠状动脉瘘(CAF)的短期疗效及安全性。
CAF较为罕见,可能伴有严重并发症,其治疗仍存在争议。经皮封堵术似乎是解剖结构合适血管的首选治疗方法,但小儿患者的数据有限。
这项回顾性、观察性、多中心全国性研究纳入了16岁以下接受先天性CAF经导管封堵术的患者。排除合并其他先天性心脏缺陷的患者。
纳入61例患者(36例女孩,25例男孩),诊断时中位年龄为0.6岁[0 - 15.4岁],手术时中位年龄为3.9岁[0 - 16岁]。48例患者(79%)的CAF较大;23例(38%)为远端CAF,22例(36%)为近端CAF。大多数患者(77%)诊断时无症状。7例患者(11%)出现充血性心力衰竭的临床体征。围手术期并发症包括3例ST段抬高型心肌梗死(仅在尝试封堵远端CAF时发生)、3例封堵器移位和1例腿部缺血。1例患者在手术关闭无法通过TCC封堵的大型远端CAF后死亡。43例患者(70%)获得随访数据,中位随访时间为91天[0 - 4824天]。2年时完全封堵的Kaplan - Meyer估计值为73±7.6%。
小儿经导管封堵术似乎有效且并发症较少。